159 related articles for article (PubMed ID: 27345788)
1. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):70-4. PubMed ID: 27345788
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):105-9. PubMed ID: 27345791
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT).
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):75-8. PubMed ID: 27345789
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia.
Nimsanor N; Jørring I; Rasmussen MA; Clausen C; Mau-Holzmann UA; Kitiyanant N; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):564-567. PubMed ID: 27789411
[TBL] [Abstract][Full Text] [Related]
5. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene.
Nimsanor N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):576-579. PubMed ID: 27934586
[TBL] [Abstract][Full Text] [Related]
6. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene.
Nimsanor N; Kitiyanant N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):556-559. PubMed ID: 27789409
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
[TBL] [Abstract][Full Text] [Related]
11. Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein.
Ehrlich M; Hallmann AL; Reinhardt P; Araúzo-Bravo MJ; Korr S; Röpke A; Psathaki OE; Ehling P; Meuth SG; Oblak AL; Murrell JR; Ghetti B; Zaehres H; Schöler HR; Sterneckert J; Kuhlmann T; Hargus G
Stem Cell Reports; 2015 Jul; 5(1):83-96. PubMed ID: 26143746
[TBL] [Abstract][Full Text] [Related]
12. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
[TBL] [Abstract][Full Text] [Related]
13. Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene.
Nimsanor N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):600-602. PubMed ID: 27934590
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
15. Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs.
Nakamura M; Shiozawa S; Tsuboi D; Amano M; Watanabe H; Maeda S; Kimura T; Yoshimatsu S; Kisa F; Karch CM; Miyasaka T; Takashima A; Sahara N; Hisanaga SI; Ikeuchi T; Kaibuchi K; Okano H
Stem Cell Reports; 2019 Oct; 13(4):684-699. PubMed ID: 31543469
[TBL] [Abstract][Full Text] [Related]
16. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.
Hallmann AL; Araúzo-Bravo MJ; Mavrommatis L; Ehrlich M; Röpke A; Brockhaus J; Missler M; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H; Hargus G
Sci Rep; 2017 Mar; 7():42991. PubMed ID: 28256506
[TBL] [Abstract][Full Text] [Related]
19. Modeling of Frontotemporal Dementia Using iPSC Technology.
Kim M; Kim HJ; Koh W; Li L; Heo H; Cho H; Lyoo CH; Seo SW; Kim EJ; Nakanishi M; Na DL; Song J
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727073
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
Lee HK; Morin P; Wells J; Hanlon EB; Xia W
Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]